{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Mitomycin_B",
  "nciThesaurus": {
    "casRegistry": "4055-40-7",
    "chebiId": "",
    "chemicalFormula": "C16H19N3O6",
    "definition": "A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus.  Bioreduced mitomycin B generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis.",
    "fdaUniiCode": "VT1IGL3D7V",
    "identifier": "C1392",
    "preferredName": "Mitomycin B",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C663"
    ],
    "synonyms": [
      "Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-8a-hydroxy-8-(hydroxymethyl)-6-methoxy-1,5-dimethyl-, 8-carbamate",
      "MITOMYCIN B",
      "Mitomycin B"
    ]
  }
}